文献速递类风湿关节炎

炎性细胞因子塑造类风湿关节炎单核细胞DNA甲基化组变化并反映疾病活动度

Inflammatory cytokines shape a changing DNA methylome in monocytes mirroring disease activity in rheumatoid arthritis.
PubMed 文献 · Ann Rheum Dis · 2019-08-01

本研究通过高通量DNA甲基化分析比较类风湿关节炎(RA)患者与健康对照的外周血单核细胞,并结合体外细胞因子刺激实验,发现RA患者单核细胞DNA甲基化组显著改变且变异性增加,与DAS28相关;高活动度患者偏离健康对照,而缓解期患者甲基化组与健康对照几乎一致。TNF-α和干扰素等疾病活动度相关细胞因子可在体外重现这些甲基化改变,并基于DNA甲基化建立了预测炎症介导疾病活动度的数学公式。

要点

  • RA患者外周血单核细胞DNA甲基化组显著改变且变异性增加,与DAS28相关。
  • 高疾病活动度患者单核细胞甲基化组偏离健康对照,缓解期患者与健康对照几乎一致。
  • TNF-α和干扰素等细胞因子可在体外重现RA患者单核细胞的DNA甲基化改变。

核心结论

  • RA疾病活动度与单核细胞甲基化组之间存在直接联系,由炎症相关细胞因子介导。
  • 基于DNA甲基化建立了预测RA及其他慢性免疫介导炎性疾病炎症介导疾病活动度的数学公式。

研究设计与样本

  • 对RA患者和对照者进行高通量DNA甲基化分析,并进行体外细胞因子刺激实验。
  • 比较同一个体在不同疾病活动阶段的单核细胞甲基化谱。

主要发现

  • RA患者外周血单核细胞DNA甲基化组与健康对照相比显示显著变化且变异性增加。
  • 单核细胞甲基化组变化与DAS28相关,高活动度患者偏离健康对照,缓解患者与健康对照几乎一致。
  • 比较同一个体不同活动阶段的甲基化谱支持单核细胞甲基化组是动态变化的。
  • TNF-α和干扰素等疾病活动度相关细胞因子在体外可重现RA患者中观察到的DNA甲基化改变。

临床怎么用

  • 单核细胞DNA甲基化谱与DAS28相关,高活动度偏离健康对照而缓解期几乎一致,提示可用于反映疾病活动度。
  • TNF-α和干扰素可重现患者单核细胞甲基化改变,提示这些细胞因子是甲基化组变化的介导因素。
  • 基于DNA甲基化的数学公式可用于预测RA及其他慢性免疫介导炎性疾病的炎症介导疾病活动度。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease that mainly targets joints. Monocytes and macrophages are critical in RA pathogenesis and contribute to inflammatory lesions. These extremely plastic cells respond to extracellular signals which cause epigenomic changes that define their pathogenic phenotype. Here, we interrogated how DNA methylation alterations in RA monocytes are determined by extracellular signals. METHODS: High-throughput DNA methylation analyses of patients with RA and controls and in vitro cytokine stimulation were used to investigate the underlying mechanisms behind DNA methylation alterations in RA as well as their relationship with clinical parameters, including RA disease activity. RESULTS: The DNA methylomes of peripheral blood monocytes displayed significant changes and increased variability in patients with RA with respect to healthy controls. Changes in the monocyte methylome correlate with DAS28, in which high-activity patients are divergent from healthy controls in contrast to remission patients whose methylome is virtually identical to healthy controls. Indeed, the notion of a changing monocyte methylome is supported after comparing the profiles of same individuals at different stages of activity. We show how these changes are mediated by an increase in disease activity-associated cytokines, such as tumour necrosis factor alpha and interferons, as they recapitulate the DNA methylation changes observed in patients in vitro. CONCLUSION: We demonstrate a direct link between RA disease activity and the monocyte methylome through the action of inflammation-associated cytokines. Finally, we have obtained a DNA methylation-based mathematical formula that predicts inflammation-mediated disease activity for RA and other chronic immune-mediated inflammatory diseases.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Rodríguez-Ubreva J, de la Calle-Fabregat C, Li T, et al. Inflammatory cytokines shape a changing DNA methylome in monocytes mirroring disease activity in rheumatoid arthritis. Ann Rheum Dis. 2019. PMID: 31371305. doi:10.1136/annrheumdis-2019-215355

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。